Inventor · disambiguated record
Gregory D. Vite
Also filed as: VITE GREGORY · VITE GREGORY D
33 granted patents·7 pending applications·827 citations·filing 1993–2023
98Inventor score
Files withBRISTOL MYERS SQUIBB CO30SQUIBB & SONS INC3VITE GREGORY D3BRISTOL MYERS SQUIBB COMPNAY1BRISTOL MYSERS SQUIBB COMPANY1
Top patents by PatentIndex Score
40 records- 0197US6291684B1Process for the preparation of aziridinyl epothilones from oxiranyl epothilonesBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Sep 18, 2001·76 cites·10 claims
- 0295US6262094B1C-21 modified epothilonesBRISTOL MYERS SQUIBB CO·Filed 2000·Granted Jul 17, 2001·141 cites·29 claims
- 0394US6916815B2C-6 modified indazolylpyrrolotriazinesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Jul 12, 2005·55 cites·10 claims
- 0494US6605599B1Epothilone derivativesBRISTOL MYERS SQUIBB CO·Filed 1998·Granted Aug 12, 2003·90 cites·62 claims
- 0592US6593115B2Preparation of epothilone intermediatesBRISTOL MYERS SQUIBB CO·Filed 2001·Granted Jul 15, 2003·31 cites·4 claims
- 0692US6399638B112,13-modified epothilone derivativesBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Jun 4, 2002·99 cites·7 claims
- 0791USRE42930EAziridinyl-epothilone compoundsVITE GREGORY D·Filed 2011·Granted Nov 15, 2011·19 cites·10 claims
- 0891US6800653B2Epothilone derivativesBRISTOL MYERS SQUIBB COMPNAY·Filed 2002·Granted Oct 5, 2004·59 cites·20 claims
- 0990US7148220B2C-6 modified indazolylpyrrolotriazinesBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Dec 12, 2006·13 cites·3 claims
- 1089US7297695B2Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Nov 20, 2007·9 cites·4 claims
- 1189US6908916B2C-5 modified indazolylpyrrolotriazinesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Jun 21, 2005·34 cites·9 claims
- 1286US6380395B112, 13-cyclopropane epothilone derivativesBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Apr 30, 2002·63 cites·22 claims
- 1385US7241755B2Epothilone derivativesBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Jul 10, 2007·4 cites·13 claims
- 1483US6831090B22,3-olefinic epothilone derivativesBRISTOL MYERS SQUIBB CO·Filed 2002·Granted Dec 14, 2004·14 cites·36 claims
- 1583US5559256AAminediol protease inhibitorsSQUIBB & SONS INC·Filed 1993·Granted Sep 24, 1996·42 cites·18 claims
- 1682US7125899B2Epothilone derivativesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted Oct 24, 2006·8 cites·20 claims
- 1781US11623965B2Prodruggable antibodies, prodrugs thereof, and methods of use and makingBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 11, 2023·1 cites·11 claims
- 1881USRE41893EEpothilone derivativesBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Oct 26, 2010·2 cites·73 claims
- 1981US7417040B2Fused tricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3BRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 26, 2008·3 cites·13 claims
- 2078USRE41911EEpothilone derivativesBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Nov 2, 2010·1 cites·62 claims
- 2178US7378426B2Fused heterotricyclic compounds as inhibitors of 17β-hydroxysteroid dehydrogenase 3BRISTOL MYERS SQUIBB CO·Filed 2005·Granted May 27, 2008·2 cites·30 claims
- 2278US7141571B2Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Nov 28, 2006·8 cites·4 claims
- 2377US8536327B2Epothilone derivativesVITE GREGORY D·Filed 2007·Granted Sep 17, 2013·1 cites·3 claims
- 2476US8921542B2Epothilone derivativesBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Dec 30, 2014·1 cites·3 claims
- 2576US7846931B2Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2008·Granted Dec 7, 2010·1 cites·1 claims
- 2675US7872145B2Aziridinyl-epothilone compoundsBRISTOL MYSERS SQUIBB COMPANY·Filed 2007·Granted Jan 18, 2011·3 cites·10 claims
- 2774US6498257B12,3-olefinic epothilone derivativesBRISTOL MYERS SQUIBB CO·Filed 1999·Granted Dec 24, 2002·38 cites·2 claims
- 2872USRE41895EEpothilone derivativesBRISTOL MYERS SQUIBB CO·Filed 2009·Granted Oct 26, 2010·0 cites·96 claims
- 2971US2023295346A1Prodruggable antibodies, prodrugs thereof, and methods of use and makingBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 3069US2015080440A1Epothilone derivativesBRISTOL MYERS SQUIBB CO·Filed 2014·Application pending·0 cites
- 3168US7211593B2C12-cyano epothilone derivativesBRISTOL MYERS SQUIBB CO·Filed 2003·Granted May 1, 2007·3 cites·19 claims
- 3258USRE43003EEpothilone derivativesVITE GREGORY D·Filed 2010·Granted Dec 6, 2011·0 cites·13 claims
- 3354US2011039838A1Pyrrolotriazine compounds as kinase inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 3452US2022251206A1Anti-ctla4 antibody prodruggable (probody) at a cdr positionBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 3549US2005209235A1C-5 Modified indazolylpyrrolotriazinesMASTALERZ HAROLD·Filed 2005·Application pending·0 cites
- 3648US2004023345A1Preparation of epothilone intermediatesFiled 2003·Application pending·0 cites
- 3747US2007275904A1Conjugates of aziridinyl-epothilone analogs and pharmaceutical compositions comprising sameBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 3845US7569725B2Anthranilic acid derivatives as inhibitors of 17β-hydroxysteroid dehydrogenase 3BRISTOL MYERS SQUIBB CO·Filed 2005·Granted Aug 4, 2009·0 cites·9 claims
- 3944US5776933AMethod of inhibiting proteaseSQUIBB & SONS INC·Filed 1995·Granted Jul 7, 1998·4 cites·15 claims
- 4039US5760036AAminediol protease inhibitorsSQUIBB & SONS INC·Filed 1995·Granted Jun 2, 1998·2 cites·16 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →